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Background: Laparoscopic Nissen fundoplication (LNF) is the most common surgical procedure for the surgical
management of gastro-esophageal reflux disease (GERD). Laparoscopic Toupet fundoplication (LTF) has been
reported to have a lower prevalence of postoperative complications yet still obtain a similar level of reflux control.
We conducted a meta-analysis to confirm the value of LNF and LTF.
Methods: PubMed, Medline, Embase, Cochrane Library and Springerlink were searched for randomized controlled
trials (RCTs) comparing LNF and LTF. Data regarding the benefits and adverse results of two techniques were
extracted and compared using a meta-analysis.
Results: Eight eligible RCTs comparing LNF (n = 625) and LTF (n = 567) were identified. There were no significant
differences between LNF and LTF with regard to hospitalization duration, perioperative complications, patient satisfaction,
postoperative heartburn, regurgitation, postoperative DeMeester scores, or esophagites. A shorter operative time and
higher postoperative lower esophageal sphincter pressure were associated with LNF. Prevalence of postoperative
dysphagia, gas-bloating, inability to belch, dilatation for dysphagia and reoperation were higher after LNF, but
subgroup analyses showed that differences with respect to dysphagia between LNF and LTF disappeared over
time. Subgroup analyses did not support “tailored therapy” according to preoperative esophageal motility.
Conclusions: LNF and LTF have equivalently good control of GERD and result in a similar prevalence of patient
satisfaction. Based on current evidence, it is not rational or advisable to abandon LNF when choosing a surgical
procedure for GERD.
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Gastro-esophageal reflux disease (GERD) is one of the
most common gastrointestinal diseases in which the gastric
contents flow into the esophagus through the incompetent
lower esophageal sphincter (LES) and can cause trouble-
some symptoms and complications [1]. According to epi-
demiology studies, GERD affects 10–28 % of Europeans [2]
and 3–7 % of Asians [3] (with an increase in prevalence in
some Asian countries), which leads to a considerable
healthcare burden and low quality of life.
Currently, the therapy approaches of GERD include life-
style modifications, proton pump inhibitor-based pharmaco-
logic therapy and surgical intervention [4]. Fundoplication
has achieved an established role in the management of
complicated GERD [5–7]. In the last two decades,
many studies including randomized controlled trials
(RCTs) and meta-analyses have shown that laparoscopic
surgery is as effective and safe as open surgery for the
treatment of GERD, while reducing the hospital stay
and incidence of complications [8–10].
There are two major anti-reflux procedures: 360° total
(Nissen) fundoplication and 270° partial (Toupet) fundo-
plication. Currently laparoscopic Nissen fundoplication
(LNF) is the most common surgical procedure for the
management of GERD offering promising long-term out-
comes [11] and has been recommended as a choice of sur-
gical therapy by the European Study Group for Antireflux
Surgery and the Society of American Gastrointestinal
Endoscopic Surgeons [12]. Nevertheless, LNF can induce
functional disorders, such as dysphagia, gas-bloating and
an inability to belch. Compared to LNF, several surgeons
have stated that laparoscopic Toupet fundoplication (LTF)
has a lower prevalence of postoperative complications
while obtaining a similar control of reflux [13], but, several
studies have failed to show a significant difference between
them [14, 15]. Also, whether preoperative esophageal mo-
tility (EM) should be considered when surgeons select a
procedure has not been elucidated. Hence, the controversy
regarding the optimal surgical method continues.
Several systematic reviews and meta-analyses have com-
pared outcomes between laparoscopic partial fundoplica-
tion and LNF up until 2013. However, generalization of all
types of partial fundoplication into one category in a re-
view is not appropriate [16–18]. In the past 3 years, sev-
eral RCTs [19–21] published comparison between the
value of LNF and LTF. Hence, it is necessary to synthesize
data from those RCTs with existing RCTs in a meta-
analysis to re-evaluate outcomes so that evidence for opti-
mal clinical practice can be provided.Methods
This meta-analysis was conducted and the results were
described according to the PRISMA statement [22].Search strategy
Following electronic databases were searched till October
2015: PubMed, Medline, Embase, Cochrane Library (issue
10, 2015) and Springerlink. A manual search was also per-
formed to identify trials in the reference lists of the articles
acquired. Only articles written in English were searched.
A search strategy using disease-specific terms (e.g., gastro-
esophageal reflux disease), management-specific terms
(e.g., laparoscopic anti-reflux fundoplication) and terms
related to surgical procedures (e.g., Nissen, Toupet, total
and partial) were adopted.
Inclusion criteria and exclusion criteria
Inclusion criteria were: (i) RCTs comparing efficacy and
adverse outcomes of LNF and 270° LTF; (ii) age ≥16 years;
(iii) laparoscopic procedure was carried out in all patients;
(iv) duration of follow-up ≥12 months; (v) raw data could
be extracted from studies to calculate outcomes; (vi) pa-
tients were diagnosed definitively preoperatively.
Exclusion criteria were: (i) non-RCTs; (ii) trials compar-
ing total and non-posterior partial fundoplication (e.g.,
total vs. anterior fundoplication); (iii) fundoplications were
carried out with laparotomy; (iv) trials involving patients
aged <16 years; (v) studies published repeatedly in differ-
ent journals; (vi) studies for which raw data could not be
extracted to obtain pooled results and the corresponding
author could not provide data requested.
Outcomes of interest and definitions
Outcome parameters were described as below. Subjective
evaluation: patient satisfaction with the intervention,
postoperative heartburn and regurgitation (defined as
subjective persistence of reflux and/or recurrence on a
dichotomous scale compared with the preoperative state).
Objective evaluation: DeMeester scores on 24-h pH
monitoring, LES pressure, and endoscopic esophagitis.
Prevalence of perioperative complications, postoperative
complications, postoperative dilatation for dysphagia, re-
operation, operating time, duration of hospitalization, and
mortality were also evaluated. Among the outcomes men-
tioned above, patient satisfaction, postoperative heartburn
and dysphagia were regarded as primary outcome parame-
ters, and the others were regarded as secondary outcome
parameters.
Data extraction
Two reviewers extracted details from selected studies in-
dependently. Data comprised (i) information provided
and the quality of the research: first author, publication
year, study population characteristics, study design, sample
size, follow-up duration, and inclusion/exclusion criteria;
and (ii) outcomes analysis, including beneficial and ad-
verse results. Disagreements between reviewers were re-
solved by discussion and consensus. If data were missing,
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provide the relevant information. Outcomes of interest
of repeated RCTs in which the study population arose
from the same cohort published in different journals at
different phases were extracted based on the article that
was published most recently.
Statistical analysis
Data extracted from eligible trials were integrated with
Review Manager 5.3 provided by the Cochrane Collabor-
ation. Outcomes reported by two or more studies were
pooled in the meta-analysis. Dichotomous and continuous
outcomes were presented as risk ratio (RR) and standard
mean difference (SMD) respectively. Dichotomous out-
comes were pooled using the Mantel-Haenszel method,
while continuous outcomes were pooled using the inverse
variance method. The fixed-effects model was used if het-
erogeneity was absent (χ2 test, P > 0.1 and I2 < 50 %);
otherwise the random-effects model was used [23]. If
excessive heterogeneity was present, data were first
rechecked. If heterogeneity persisted, sensitivity orRecords after duplicates 
removed
(n=1802)






Studies included in qualitative synthe
(n=8)
Records identified through 
electronic databases searching 
(n=4266)
Fig. 1 A flow chart showing the process and result of trials screening. RCTsubgroup analyses were undertaken to explore its
causes. Subgroup analysis was performed to assess the
impact of follow-up duration and EM.Quality assessment
According to Cochrane criteria guidelines, all included
studies were evaluated to ascertain if methodological
bias was present [24].Results
Description of studies
After screening of trials according to inclusion and ex-
clusion criteria, eight RCTs [19–21, 25–29] were identi-
fied, including 1192 patients, of whom 625 (52.43 %)
underwent LNF and 567 (47.57 %) underwent LTF
(Fig. 1). Included studies were published between 2003
and 2015. Duration of follow-up ranged from 12 to
60 months. Not all studies provided data regarding out-
comes of interest. In two trials [19, 27], whether the
baseline information of two groups was similar was notAdditional records identified 
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Editorials and comments (n=14)
Full-text articles excluded (n=48):
Children trials (n=14)
Laparotomy fundoplication (n=6)
Non-270° partial fundoplication (n=8)
Anterior partial fundoplication(n=9)
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Duplicate publication (n=3)
Raw data could not be extracted (n=3)
s, randomized controlled trials
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Table 1.
Quality assessment
The methodological quality of included trials is shown
in Table 2. Main limitations resulted from poor description
of randomization processes [19, 26], as well as a lack of (or
poor description of) double-blinding processes [19, 20, 26].
In-hospital characteristics
Operating time
Six RCTs [19, 21, 25, 27–29] reported operating time for
LNF and LTF. Because of significant heterogeneity, the
random-effects model was used to pool data. Meta-
analysis revealed a significant difference in this param-
eter between the two groups (SMD = –0.54 min, 95 %
confidence interval (CI), –0.84 to –0.24 min, P = 0.0004)
(Table 3). Operating time was shorter in patients under-
going LNF. Sensitivity analyses were done upon consid-
eration of whether division of the short gastric vessels
was a possible cause of heterogeneity. After removal of
two studies [19, 25], heterogeneity disappeared and the
result did not change (four studies with division of short
gastric vessels: SMD = –0.34 min, 95 % CI, –0.51 to –
0.16 min, P = 0.0001, χ2 test, P = 0.51, I2 = 0 %).
Duration of hospitalization
Four studies [19, 21, 25, 28] reported duration of
hospitalization after LNF and LTF. Meta-analysis revealed
no significant difference in this parameter between the
two arms (SMD= –0.05 days, 95 % CI, –0.41 to 0.32 days,
P = 0.80) (Table 3).
Perioperative complications
Five studies [21, 25–28] reported perioperative compli-
cations after LNF and LTF. Meta-analysis revealed no
significant difference in this parameter between the two
groups (RR = 0.78, 95 % CI, 0.37 to 1.68, P = 0.53)
(Fig. 2).Table 1 The basic characteristics of included randomized clinical tria
Source Country N Sex ratio Age (year
(LNF/LTF) (Male/Female) (LNF/LTF)
Chrysos 2003[25] Greece 14/19 18/15 61.7 ± 8.7
Guérin 2007[26] Belgium 77/63 86/54 NR
Strate 2008[27] Germany 100/100 121/79 56(20–80)
Booth 2008[28] England 64/63 84/43 45.3(21–8
Shaw 2010[29] South Africa 50/50 60/40 45.2(28–7
Qin 2013[19] China 215/168 194/189 56.3(34–8
Koch 2013[20] Austria 62/63 78/47 50.32(20–
Wang 2015[21] China 43/41 44/40 57 ± 13.2/
LNF laparoscopic Nissen fundoplication, LTF laparoscopic Toupet fundoplication, BMPatient satisfaction
Six trials [21, 25–29] reported patient satisfaction after
LNF and LTF. Four RCTs counted the number of patients
who were “very satisfied”/“satisfied” with the intervention.
The other two RCTs employed a Visick scale to measure
patient the degree of patient satisfaction. The Visick score
ranged from I (excellent) to IV (poor) based on postopera-
tive symptoms [30]. For this report, Visick scale grade I/II
was defined as “very satisfied”/“satisfied” with the proced-
ure. Meta-analysis revealed no significant difference in this
outcome between the two arms (RR = 1.02, 95 % CI, 0.96
to 1.08, P = 0.49) (Fig. 2).
Recurrence of GERD symptoms and prevalence of
reoperation
Postoperative heartburn
Seven studies [19, 21, 25–29] reported postoperative
heartburn after LNF and LTF. Excessive heterogeneity
existed, so the random-effects model was used to pool
data. Meta-analysis revealed no significant difference in
this parameter between the two arms (RR = 0.88, 95 %
CI, 0.48 to 1.64, P = 0.70) (Fig. 2). After removal of one
RCT [19], heterogeneity was reduced significantly, and
the result did not alter (RR = 1.11, 95 % CI, 0.79 to 1.57,
P = 0.54, χ2 test, P = 0.67, I2 = 0 %).
Postoperative regurgitation
Three studies [21, 25, 28] reported postoperative regur-
gitation after LNF and LTF. Meta-analysis revealed no
significant difference in this outcome between the two
groups (RR = 1.18, 95 % CI, 0.54 to 2.60, P = 0.67)
(Fig. 2).
Reoperation
Five studies [20, 25, 27–29] reported the prevalence of
reoperation after LNF and LTF. Meta-analysis revealed a
significant difference in this parameter between the two
groups (RR = 3.16, 95 % CI, 1.49 to 6.68, P = 0.003)ls
s) BMI or Weight (Kg) DSGV Follow–up
(LNF/LTF) (months)
/59.2 ± 11.5 NR NO 12
Mean BMI 27.9/27.2 YES 36
Median BMI 26.4(18.9–40.4) YES 24
6)/44.2(19–69) Mean Weight 81.6/80.2 YES 12
2)/45.6(25–67) Mean BMI 29.3 ± 5.2/29.2 ± 5.2 YES 60
2) NR NO 12
76)/51.87(25–81) Mean BMI 28.18(19.47–41.80)/
27.32(19.66–3.86)
YES 12
57 ± 10.8 Mean BMI 23.5 ± 2.7/2.5 ± 3.4 YES 24
I body mass index, DSGV division of short gastric vessels, NR not report
Table 2 Risk of bias summary
① ② ③ ④ ⑤ ⑥ ⑦
Chrysos 2003[25] LR LR LR LR LR LR LR
Guérin 2007[26] UR UR UR LR LR LR LR
Strate 2008[27] LR LR LR LR LR LR LR
Booth 2008[28] LR LR LR LR LR LR LR
Shaw 2010[29] LR LR LR LR LR LR LR
Qin 2013[19] HR LR UR UR LR LR LR
Koch 2013[20] LR LR HR LR LR LR LR
Wang 2015[21] LR LR LR LR LR LR LR
①:Random sequence generation; ②:Allocation concealment; ③:Blinding of
participants and personnel ④:Blinding of outcomes assessment; ⑤:Incomplete
outcome data; ⑥:Selective reporting; ⑦:Other bias. LR low risk, UR unclear risk,
HR high risk




Preoperative DeMeester scores Six studies [19–21, 25,
27, 29] reported preoperative DeMeester scores on 24-h
pH monitoring. Meta-analysis revealed a significant
difference in this parameter between the two arms
(SMD = 0.17, 95 % CI, 0.02 to 0.32, P = 0.02) (Table 3).
Slightly higher mean DeMeester scores before LNF
were documented.
Postoperative DeMeester scores The same six studies
[19–21, 25, 27, 29] mentioned above reported postopera-
tive DeMeester scores on 24-h pH monitoring. Because
of significant heterogeneity, the random-effects model
was used to pool data. Meta-analysis revealed no signifi-
cant difference in this parameter between the two arms
(SMD = –0.20, 95 % CI, –0.59 to 0.18, P = 0.30) (Fig. 3).
LES pressure
Preoperative LES pressure Seven studies [19–21, 25,
27–29] reported preoperative LES pressure. Meta-
analysis revealed no significant difference in thisTable 3 Meta-analysis of some outcome parameters after LNF and L
Outcome n Heterogeneity
LNF LTF I2
Operating time 486 441 77 %
Duration of hospitalization 336 291 13 %
Reoperation 274 282 4 %
Preoperative DeMeester scores 484 441 0 %
Preoperative LES pressure 548 504 20 %
Postoperative esophagitis 317 277 0 %
LNF laparoscopic Nissen fundoplication, LTF laparoscopic Toupet fundoplication, SMparameter between the two groups (SMD = –0.06 mmHg,
95 % CI, –0.21 to 0.09 mmHg, P = 0.43) (Table 3).Postoperative LES pressure The same seven studies
[19–21, 25, 27–29] mentioned above reported postoper-
ative LES pressure. Meta-analysis revealed a significant
difference in this parameter between the two groups
(SMD = 0.61 mmHg, 95 % CI, 0.48 to 0.74 mmHg, P <
0.00001) (Fig. 3). The result suggested that LNF was as-
sociated with a higher mean postoperative LES pressure
compared to LTF.Postoperative esophagitis
Three studies [19, 25, 27] reported postoperative esopha-
gitis after LNF and LTF. Meta-analysis revealed no statisti-
cally difference in this parameter between the two groups
(RR = 0.98, 95 % CI, 0.81 to 1.18, P = 0.80) (Table 3).Postoperative complications
Postoperative dysphagia
Considering duration of follow-up and EM were possible
factors influencing dysphagia, subgroup analyses were
conducted based on these factors.Subgroup analyses of dysphagia based on duration of
follow-up Seven studies [19, 21, 25–29] reported post-
operative dysphagia, including five studies [19, 21, 25,
27, 28] with duration of follow-up <36 months and two
studies [27, 29] with duration of follow-up ≥36 months.
When total-group analyses were performed, meta-analysis
revealed a significant difference in this parameter between
the two arms (RR = 2.75, 95 % CI, 1.69 to 4.50, P < 0.0001)
(Fig. 4). Findings showed a lower prevalence of dyspha-
gia for patients who had undergone LTF. In the sub-
group with a follow-up <36 months, results also
favored LTF (RR = 2.69, 95 % CI, 1.62 to 4.49, P =
0.0001) (Fig. 4). Nevertheless, in the subgroup with a
follow-up ≥36 months, the prevalence of postoperative
dysphagia was similar between the two groups (RR =
3.47, 95 % CI, 0.58 to 20.60, P = 0.17) (Fig. 4).TF
test Analysis
model




0.0007 Random SMD –0.54 (–0.84, –0.24) 0.0004
0.28 Fixed SMD –0.05 (–0.41, 0.32) 0.8
0.37 Fixed RR 3.16 (1.49, 6.68) 0.003
0.45 Fixed SMD 0.17 (0.02, 0.32) 0.02
0.29 Fixed SMD –0.06 (–0.21, 0.09) 0.43
0.46 Fixed RR 0.98 (0.81, 1.18) 0.8
D standard mean difference, RR risk ratio, LES lower esophageal sphincter
Fig. 2 Meta-analysis of perioperative complications (a), patient satisfaction (b), postoperative heartburn (c), and regurgitation (d) after LNF
and LTF
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tive EM In the subgroup with normal EM subgroup
preoperatively, subgroup analyses revealed a significantdifference in the outcomes between the two arms (sub-
group 1: RR = 3.15, 95 % CI, 1.25 to 7.94, P = 0.01)
(Fig. 4). The result showed a lower prevalence of
Fig. 3 Meta-analysis of postoperative DeMeester scores (a) and LES pressure (b) after LNF and LTF
Du et al. BMC Gastroenterology  (2016) 16:88 Page 7 of 11dysphagia for patients who had undergone LTF. How-
ever, in the subgroup with abnormal EM or subgroup of
LNF with normal EM and LTF with abnormal EM pre-
operatively, subgroup analyses failed to find a difference
(subgroup 2: RR = 1.88, 95 % CI, 0.88 to 4.02, P = 0.11;
subgroup 3: RR = 1.25, 95 % CI, 0.50 to 3.12, P = 0.63)
(Fig. 4).
Postoperative dilatation for dysphagia
Four studies [21, 25, 27, 28] reported postoperative dila-
tation after LNF and LTF. Meta-analysis revealed a sig-
nificant difference in this parameter between the two
arms (RR = 2.99, 95 % CI, 1.22 to 7.35, P = 0.02) (Fig. 5).
The result showed that LTF was associated with a slightly
lower occurrence of dilatation for dysphagia compared to
LNF.
Postoperative gas-bloating
Four studies [21, 25, 27, 28] reported postoperative gas-
bloating after LNF and LTF. Meta-analysis revealed a
significant difference in this parameter between the two
arms (RR = 1.62, 95 % CI, 1.25 to 2.09, P = 0.0002)
(Fig. 5). The result showed a lower occurrence of post-
operative gas-bloating for patients who underwent LTF.
Postoperative inability to belch
Four studies [21, 26–28] reported postoperative inability
to belch after LNF and LTF. Meta-analysis revealed a
significant difference in this parameter between the twogroups (RR = 2.04, 95 % CI, 1.25 to 3.33, P = 0.004)
(Fig. 5). The result showed a lower occurrence of the in-
ability to belch for patients who underwent LTF.
Mortality
As no death was associated with these two surgical
methods in hospital or during follow-up, the two arms
could not be compared with regard to mortality.
Sensitivity analysis
For two studies [19, 27], whether the baseline information
of two arms was similar was not known. After removal of
these two studies from the pooling analysis, the results
did not alter substantially with regard to the primary
outcomes: patient satisfaction, postoperative heartburn
and postoperative dysphagia.
Discussion
Since the first laparoscopic fundoplication was undertaken
for GERD in 1991, laparoscopic surgery has been the “gold
standard” for patients with medical-refractory GERD [31].
Although LNF is classic procedure for the treatment of
GERD, it is challenged by LTF with less functional
disorders.
In the last two decades, several RCTs have been con-
ducted to compare LNF with LTF, but the results have been
inconclusive. Between 2010 and 2015, four meta-analyses
[32–35] comparing LNF with LTF were published. How-
ever, in the included trials, LTF was done with various
Fig. 4 Subgroup analyses of postoperative dysphagia according to duration of follow-up (a) and preoperative EM (b)
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Fig. 5 Meta-analysis of postoperative dilatation for dysphagia (a), gas-bloating (b) and inability to belch (c) after LNF and LTF
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geneity between trials and reduce the reliability and accur-
acy of the findings of the meta-analyses above. In addition,
these meta-analyses neglected the comparability of baseline
information of LNF and LTF. Several trials [19–21] of
large-scale and long-term follow-up have been published in
recent years, so re-evaluation and syntheses of data in exist-
ing trials are important.
According to the findings from the present meta-
analysis, the following conclusions can be drawn. First,
the prevalence of patient satisfaction was similar between
LNF and LTF, and was high (LNF, 89.17 %; LTF, 87.42 %).
Second, LTF was as effective as LNF with respect to
symptom control. Third, the prevalence of postopera-
tive dysphagia was higher after LNF, but with increasing
duration of follow-up, the difference between two arms
disappeared. Fourth, LNF was associated with higher
LES pressure.This report demonstrated that the operating time of
LTF was longer than that of LNF, which might be due to
the fact that the gastric fundus and both sides of the
esophagus should be secured, respectively. Prevalence of
perioperative complications between the two groups was
not significantly different. But it is notable that Strate
et al. [27] and Booth et al. [28] reported a perforation in
the fundal wrap and an episode of perioperative bleeding
after LTF. And Guérin et al. [26] also observed in-
hospital bleeding. This phenomenon may be because the
esophagus does not have a serosal layer and gastric
fundus and both sides of the esophagus wall need to be
sutured together, which may increase the risk of per-
foration and bleeding.
Heartburn and regurgitation are typical symptoms of
GERD. Our report showed that LNF and LTF were simi-
lar with regard to reflux control. Importantly, objective
parameters are not always in accordance with the
Du et al. BMC Gastroenterology  (2016) 16:88 Page 10 of 11symptoms or complaints of patients [27, 36, 37]. The
value of laboratory examinations is limited for the diag-
nosis and evaluation of therapeutic efficacy for GERD, so
the definition of “recurrent GERD” based on laboratory
measurements alone may not be appropriate. Symptoms
combined with objective parameters should be the main
indications for surgical therapy, a view that is consistent
with that of Tan et al [34].
With better control of GERD, LNF was previously
regarded as the standard treatment for GERD. However,
this concept has been challenged owing to postoperative
functional disorders. We have shown that LNF is associated
with a higher incidence of postoperative dysphagia, gas-
bloating and inability to belch. However, subgroup analyses
suggested that differences in the prevalence of dysphagia
between two techniques disappeared over time. Further-
more, two decades follow-up results of a RCT [38] compar-
ing open Nissen and Toupet demonstrated no difference in
the prevalence of postoperative complications. As a reason-
able and accurate index for assessing the efficacy of surgical
treatment for GERD [39, 40], the patient satisfaction was
high (≈90 %) and comparable between the two arms.
As for whether preoperative EM was an indication for
“tailored therapy”, the subgroup analyses showed that
EM was not correlated with postoperative dysphagia,
indicating that “tailored therapy” according to EM was
not indicated, which was consistent with other reports
[30, 33]. It should be noted that the definition of EM in
the included studies was not consistent, which might
affect the ability to reach true conclusion.
With regard to reoperation, the most common causes
were complications, recurrence of reflux symptoms, and
others conditions. Specific data could not be obtained,
so subgroup analyses based on causes could not be done.
For baseline information’s comparability was uncertain
in two studies [19, 27], sensitivity analyses were con-
ducted by removing these two studies for three primary
outcomes, thought the results were not altered, which
was neglected in previous meta-analyses [32–35].
In contrast to previous reviews [32–34], some large-
scale studies included in our report were published in
the last 3 years, and outcomes were evaluated with long-
term follow-up (12–60 months). Hence, the results of
our meta-analysis are of credibility and stability. The limi-
tations of our meta-analysis were: (i) methodological qual-
ity of some studies included in the meta-analysis was poor
(lack of blinding and description of randomization pro-
cesses); (ii) the number of included studies and sample
size was small; and (iii) definitions or evaluation criteria in
different studies were not consistent.
Conclusions
In conclusion, our meta-analysis suggests that LNF and
LTF have equivalently good control of GERD and couldresult in a similar prevalence of patient satisfaction. It is
not rational or advisable to abandon LNF based on
current evidence when choosing a surgical procedure for
GERD. More large-scale, multicenter, high-quality, RCTs
with a longer duration of follow-up are required to
further clarify the value of LNF and LTF.
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